PT Murni Sadar Tbk
IIDX:MTMH925.00
IDR
-30.00
(-3.14%)
ISIN
ID1000167307
Return %
Stock
S&P 500
1Y
-22.59
14.20
3Y
-33.93
81.12
5Y
- -
68.34
Capital Structure
IDR
•
in mil. unless spec.Working Capital
IDR
•
in mil. unless spec.Growth Rates
IDR
•
in mil. unless spec.Quarterly Revenue
IDR
•
in mil. unless spec.Quarterly Earnings Per Share
IDR
•
in mil. unless spec.Quarterly Dividends Per Share
IDR
•
in mil. unless spec.Company Description
- CEO
- Mutiara
- Full Time Employees
- 3,550
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Jalan Jawa No. 2, LK II Medan SU Indonesia 20231
- IPO Date
- Apr 20, 2022
- Website
- rsmurniteguh.com
- Similar Companies
- Business
- PT Murni Sadar Tbk operates private hospitals in Indonesia with a focus on oncology and cardiovascular services. Founded in 2010 and headquartered in Medan, North Sumatra, the company manages a network of facilities including Murni Teguh Memorial Hospital in Medan; Murni Teguh Rosiva Mother and Child Hospital in Medan; Murni Teguh Methodist Susanna Wesley Hospital in Medan; Eria Hospital (formerly Aminah) in Pekanbaru, Riau; Murni Teguh Sudirman Hospital in Jakarta; Aminah Ciledug Hospital in Tangerang; Murni Teguh Tuban Hospital in Bali; Murni Teguh Naripan Hospital in Bandung; Murni Teguh Pematang Siantar Hospital; and Murni Teguh Horas Insani Hospital, providing a total bed capacity exceeding 1,000 units across these locations. Core services encompass outpatient clinics such as specialist, family health, general, dental, tropical disease, travel medicine, and pain clinics; laboratory services including clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology; radiotherapy with LINAC, CT-simulator, brachytherapy, and treatment planning; radiology featuring general X-ray, ultrasonography, mammography, 128-slice CT scan, 1.5 Tesla MRI, and interventional radiology; cardiovascular diagnostics and interventions via ECG, treadmill test, echocardiography, holter monitoring, cardiac catheterization lab; endoscopy procedures like esophagoscopy, gastroscopy, colonoscopy, bronchoscopy, and ERCP; medical rehabilitation including physiotherapy, speech therapy, occupational therapy; emergency and inpatient care with ICU/ICCU/PICU/NICU; operating theaters; pharmacy; medical check-ups; IVF via Murni Teguh Smart IVF; home care; palliative care; and additional specialized offerings such as oncology chemotherapy, lifestyle clinic, and ambulance services. The company conducts operations primarily in Sumatra, Java, and Bali regions, serving diverse patient segments through its subsidiaries PT Murni Sadar Kasih Abadi, PT Sahid Sahirman Memorial Hospital, PT Medikarya Aminah Utama, and PT Rumah Sakit Ibu dan Anak Rosiva. Recent developments include the acquisition of a 90% stake in PT Riau Sarana Medika, operator of Eria Hospital in Pekanbaru, for IDR 52.4 billion completed in March 2024 to expand health service reach and enhance operational efficiency; strategic international partnerships with Asan Medical Center and Yonsei University in Korea, Harley Street Heart & Vascular Centre, Icon Cancer Centre, and National University Cancer Institute in Singapore, and Indraprastha Apollo Hospitals in India; ongoing construction of Murni Teguh Pejaten Hospital in South Jakarta and Murni Teguh Gama City in Deli Serdang; and the groundbreaking ceremony for RS Murni Teguh Ciledug on September 23, 2025, marking further expansion in Tangerang.